Jan 20 (Reuters) - Merck & Co said it agreed to
enter into a settlement and license agreement with Bristol-Myers
Squibb Co and Ono Pharmaceutical Co Ltd to
resolve all global patent-infringement litigation related to its
cancer drug, Keytruda.
Read more
No comments:
Post a Comment